Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isosorbide Dinitrate in Fontan physiology
NCT04297241Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Dec 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of isosorbide dinitrate, sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Number of Participants Who Experience an Adverse Reaction to the Study Medication at 6 weeks. Started Dec 2019; status: completed.
02
Drugs
isosorbide dinitrate
Beyond the preview
Go deeper on NCT04297241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04297241.